1
by Wells, Charlotte, Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
... variability in patient care between physicians and patients that is not explained by the patients' condition...

2
by Wells, Charlotte, Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Cost-Benefit Analysis...

3
by Wells, Charlotte, MacDougall, Danielle
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Long-Term Care / methods...

4
by Wells, Charlotte, MacDougall, Danielle
Published 2020
Canadian Agency for Drugs and Technologies in Health
... irrigation, and lower proteolytic activity. However, HDC can be a costly procedure, and its effectiveness...

5
by Kaulback, Kellee, Jones, Sarah, Wells, Charlotte, Felipe, Eldiflor
Published 2017
Canadian Agency for Drugs and Technologies in Health
...The purpose of this review is to evaluate the clinical and cost-effectiveness of hyaluronic acid...

6
by Kaulback, Kellee, Jones, Sarah, Wells, Charlotte, Felipe, Eldiflor
Published 2017
Canadian Agency for Drugs and Technologies in Health
...The purpose of this review is to evaluate the clinical and cost-effectiveness of hyaluronic acid...